Mark J. Ingerman

Comparison of two beta-lactamase-producing strains of Streptococcus faecalis

B E Murray, D. Church, Audrey Wanger et al. · Antimicrobial Agents and Chemotherapy · 1986 · 98 citations · Full text

Antimicrobial Resistance Gene, Antimicrobial Susceptibility, Health Sciences +13

 -Lactamase Production in Experimental Endocarditis Due to Aminoglycoside-Resistant Streptococcus faecalis

Mark J. Ingerman, P. G. Pitsakis, A. Rosenberg et al. · The Journal of Infectious Diseases · 1987 · 66 citations

Penicillin Inactivation, Antimicrobial Resistance Gene, Antimicrobial Susceptibility +15

Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis.

Margaret Trexler Hessen, Mark J. Ingerman, D KAUFMAN et al. · PubMed · 1987 · 59 citations

The Importance of Pharmacodynamics in Determining the Dosing Interval in Therapy for Experimental Pseudomonas Endocarditis in the Rat

Mark J. Ingerman, P. G. Pitsakis, Alexander F. Rosenberg et al. · The Journal of Infectious Diseases · 1986 · 57 citations

Vancomycin. A new old agent.

Mark J. Ingerman, Jerome Santoro · PubMed · 1989 · 36 citations